Quinone-Containing Conjugates for Synergistic Combinations

This inventive concept integrates quinone-containing conjugates with distinct technologies like AI, IoT, blockchain, and new materials to create a more powerful system for detecting and treating proliferative disorders.

The original patent disclosed quinone-containing conjugates for detecting and treating proliferative disorders, but it had limitations in terms of efficacy monitoring, supply chain management, and material properties. This new inventive concept addresses these limitations by synergistically combining the conjugates with AI, IoT, blockchain, and new materials.

The new system comprises a quinone-containing conjugate of formula (I) and an artificial intelligence module for analyzing the conjugate's binding affinity to tumor cells. Additionally, the system can be integrated with IoT-enabled devices for monitoring treatment efficacy, blockchain-based platforms for secure supply chain management, and composite materials comprising biodegradable polymers for targeted cancer therapy. The system can also utilize machine learning algorithms to predict the efficacy of the conjugate in treating proliferative disorders.

The new claims introduce novel synergistic combinations of quinone-containing conjugates with AI, IoT, blockchain, and new materials, which are non-obvious and provide significant improvements over the original patent.

Alternative embodiments of the inventive concept include using different AI algorithms, IoT devices, or blockchain platforms. Variations of the composite material could include different biodegradable polymers or conjugate formulations.

The inventive concept has potential commercial applications in the fields of cancer therapy, diagnostics, and pharmaceuticals. The target market includes pharmaceutical companies, research institutions, and hospitals.